The malaria testing and treatment landscape in mainland Tanzania, 2016.

ABSTRACT:

Background

Understanding the key characteristics of malaria testing and treatment is essential to the control of a disease that continues to pose a major risk of morbidity and mortality in mainland Tanzania, with evidence of a resurgence of the disease in recent years. The introduction of artemisinin combination therapy (ACT) as the first-line treatment for malaria, alongside policies to promote rational case management following testing, highlights the need for evidence of anti-malarial and testing markets in the country. The results of the most recent mainland Tanzania ACTwatch outlet survey are presented here, including data on the availability, market share and price of anti-malarials and malaria diagnosis in 2016.

Methods

A nationally-representative malaria outlet surve

SUBMITTER: ACTwatch Group 

PROVIDER: S-EPMC5437635 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature